Mapping dopamine function in primates using pharmacologic magnetic resonance imaging.
about
The blood-brain barrier is intact after levodopa-induced dyskinesias in parkinsonian primates--evidence from in vivo neuroimaging studiesNonhuman primate positron emission tomography neuroimaging in drug abuse researchNeuroimaging and drug taking in primatesEvolution of extra-nigral damage predicts behavioural deficits in a rat proteasome inhibitor model of Parkinson's diseaseA receptor-based model for dopamine-induced fMRI signal.fMRI of cocaine self-administration in macaques reveals functional inhibition of basal gangliaDevelopment of an apparatus and methodology for conducting functional magnetic resonance imaging (fMRI) with pharmacological stimuli in conscious rhesus monkeys.Cocaine-induced brain activation detected by dynamic manganese-enhanced magnetic resonance imaging (MEMRI).Cerebral blood volume MRI with intravascular superparamagnetic iron oxide nanoparticles.Data collection and analysis strategies for phMRISplitting the difference: how does the brain code reward episodes?Brain imaging in nonhuman primates: insights into drug addiction.Nonhuman primate neuroimaging and the neurobiology of psychostimulant addiction.IRON fMRI measurements of CBV and implications for BOLD signalPharmacologic magnetic resonance imaging (phMRI): imaging drug action in the brain.Quantitative pharmacologic MRI: mapping the cerebral blood volume response to cocaine in dopamine transporter knockout miceNonhuman primate models of Parkinson's disease.Nociceptin/orphanin FQ receptor blockade attenuates MPTP-induced parkinsonism.The effects of Psychotropic drugs On Developing brain (ePOD) study: methods and designDopaminergic system dysfunction in recreational dexamphetamine usersSuccessful function of autologous iPSC-derived dopamine neurons following transplantation in a non-human primate model of Parkinson's disease.Quantitative pharmacologic MRI in mice.Development of histocompatible primate-induced pluripotent stem cells for neural transplantationRepeated dexamphetamine treatment alters the dopaminergic system and increases the phMRI response to methylphenidate.Influence of cell preparation and target location on the behavioral recovery after striatal transplantation of fetal dopaminergic neurons in a primate model of Parkinson's disease.Pharmacologic MRI (phMRI) as a tool to differentiate Parkinson's disease-related from age-related changes in basal ganglia function.Pharmacological MRI (phMRI) monitoring of treatment in hemiparkinsonian rhesus monkeysIn vivo evidence of D3 dopamine receptor sensitization in parkinsonian primates and rodents with l-DOPA-induced dyskinesias.Imaging brain regional and cortical laminar effects of selective D3 agonists and antagonistsDopaminergic response to graded dopamine concentration elicited by four amphetamine doses.The age-dependent effects of a single-dose methylphenidate challenge on cerebral perfusion in patients with attention-deficit/hyperactivity disorderAge-Dependent Effects of Methylphenidate on the Human Dopaminergic System in Young vs Adult Patients With Attention-Deficit/Hyperactivity Disorder: A Randomized Clinical Trial.Tracking extranigral degeneration in animal models of Parkinson's disease: quest for effective therapeutic strategies.Pharmacological MRI of the choroid and retina: blood flow and BOLD responses during nitroprusside infusion.The use of pharmacological-challenge fMRI in pre-clinical research: application to the 5-HT system.Functional modulation of G-protein coupled receptors during Parkinson disease-like neurodegeneration.Enhanced binding of metabotropic glutamate receptor type 5 (mGluR5) PET tracers in the brain of parkinsonian primatesStriatal vessels receive phosphorylated tyrosine hydroxylase-rich innervation from midbrain dopaminergic neurons.Involving the cerebellum in cocaine-induced memory: pattern of cFos expression in mice trained to acquire conditioned preference for cocaine.Neural effects of MDMA as determined by functional magnetic resonance imaging and magnetic resonance spectroscopy in awake marmoset monkeys.
P2860
Q24605294-C89325B5-5D88-416B-B4BA-2A1BE9ABF440Q24607038-32730C32-C1F8-4351-8862-2AE6F88B5B44Q24631230-A140D5B4-C112-4078-8B67-4925D5646AE8Q27350440-BA85F960-BF0E-495C-9B3A-55B81CF3C890Q30434854-255CB74B-3C3D-4DF4-A381-8B8C8B5BCBD0Q30473348-17D5214D-1868-49F8-869F-A2536DF7EB00Q30474528-238071E3-A957-4095-991E-1679E80BC0C5Q30479602-CC7F6BA0-6D3B-47C1-A0ED-8B4775A4C62CQ30580013-0B64B3E7-5E39-4636-9173-586082D2BB18Q30773900-535B70ED-ABC7-46B6-9321-1D9E7A0D4DC7Q31108485-D57E3D50-8E5D-4DB8-B32C-BFF23E4C8D29Q31141730-97C2EA33-A67F-4746-BE24-C3E64BAF7D8FQ33383360-415CA499-26FE-4966-9A35-62181F05BD3CQ34142546-728C1EE7-A02A-4BA2-BD1D-40A06901094EQ34229087-D885C9BF-CB98-47D3-8D83-6370E367C070Q34562215-F065C0BC-A928-4A7D-B4ED-785503EE1C4BQ34665820-0447A949-8FDE-49C0-83D5-0B44C47D8316Q34769948-B5038D41-C202-4E73-B787-DA04CB7F121CQ35098070-1F4F351E-4776-441B-AE39-07991B75081EQ35200020-518B543B-DD17-4449-A0A5-BB1A53F6E520Q35711351-2A458D66-94F5-4F45-A84C-B186DE1F5E84Q35798805-FC7B3CD9-EFD2-40F8-BA8F-1C27A76873F7Q35924439-EA174773-FC54-49E9-A127-254D7820505CQ36291652-DB80EDC9-F7D1-4BFF-BC5F-647B7DFF586FQ36326475-7E1BFF73-DD50-49FF-B270-65FA1B6C451EQ36647035-8A951B5A-0C5F-4109-8B5C-C2445BD2DF66Q37020931-410D74E8-66E1-4113-93B6-BD00E6D0CF78Q37173272-44C9F8FB-1E15-486E-9416-E09EAF3F8FF6Q37294037-DFC972B6-4531-4311-8F1A-CA8FA37D6DA7Q37377944-7019B614-B5B3-44B1-8775-15C3716C982FQ37472334-D83FA422-3B0B-43F5-8FD8-A6346660F0DDQ37607582-E4AC6C3A-FB1B-4A5C-B7C0-C5D114BAFC7FQ37880260-0E617D2D-9EE8-47D7-B61B-00734F075327Q42073284-EF5AC8A1-F1AB-4B43-9E75-37974AE7AF96Q42169859-DF2A7FE9-3BFE-4015-98F3-92586ADC6350Q42174379-33BCAD91-5939-41C9-A958-82804EB1BFA0Q42434375-B7B12E49-7067-4CB2-8916-51287F737C95Q42839787-497E8F8E-3893-42F3-8C7D-3C7DF504E95EQ45347129-CFDE4649-80A0-44D0-A1B4-C3AC9C7F0799Q48369906-7FB0B095-E798-4B6E-A5C5-36C0D00F7BF5
P2860
Mapping dopamine function in primates using pharmacologic magnetic resonance imaging.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on October 2004
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Mapping dopamine function in primates using pharmacologic magnetic resonance imaging.
@en
Mapping dopamine function in primates using pharmacologic magnetic resonance imaging.
@nl
type
label
Mapping dopamine function in primates using pharmacologic magnetic resonance imaging.
@en
Mapping dopamine function in primates using pharmacologic magnetic resonance imaging.
@nl
prefLabel
Mapping dopamine function in primates using pharmacologic magnetic resonance imaging.
@en
Mapping dopamine function in primates using pharmacologic magnetic resonance imaging.
@nl
P2093
P2860
P1476
Mapping dopamine function in primates using pharmacologic magnetic resonance imaging.
@en
P2093
Anna-Liisa Brownell
Bruce G Jenkins
Ole Isacson
Rosario Sanchez-Pernaute
Yin-Ching Iris Chen
P2860
P304
P356
10.1523/JNEUROSCI.1558-04.2004
P407
P577
2004-10-01T00:00:00Z